Cellectis SA at Barclays Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. My name is Gena Wang. I'm a SMID cap biotech analyst at Barclays.
Welcome to our second virtual Global Healthcare Conference. First, I wish everyone stayed healthy. And I would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our next speaker, Simon Harnest, Senior VP of Corporate Strategy and Finance from Cellectis. Simon, I hand over to you.
Thank you so much, Gena. I'm actually going to share my screen, so just let me know if you see this. And thank you so much for hosting me today. And I'm always very excited to present at Barclays, really one of the leading research teams in the world, and especially covering gene editing. So Gena, thank you so much for having us.
I would like to give an introduction on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
